Targeted degradation of Pin1 by an antagonistic peptide enhances gemcitabine therapy in pancreatic cancer. [PDF]
Chen M +8 more
europepmc +1 more source
ZMIZ2 interacts with PIN1 to promote lung adenocarcinoma EMT and metastasis via activation of the PI3K/AKT pathway. [PDF]
Su Z +14 more
europepmc +1 more source
Both brefeldin A and latrunculin B treatment induces cytoplasmic aggregation of plasma membrane-associated proteins in epidermal cells, but not in columella cells. [PDF]
Chen A, Wang Q, Sheng X.
europepmc +1 more source
An increase of <i>NPY1</i> expression leads to inhibitory phosphorylation of PIN-FORMED (PIN) proteins and suppression of <i>pinoid</i> (<i>pid</i>) null mutants. [PDF]
Mudgett M +5 more
europepmc +1 more source
Dual-site spatiotemporal and simultaneous inhibition on PIN1 via arsenic-retinoic albumin nanoparticles enables synergistic oncotherapy. [PDF]
Yang D +10 more
europepmc +1 more source
The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer. [PDF]
Bowman CL +36 more
europepmc +1 more source
TMO5 regulates PIN1 polarity convergence and organogenesis downstream of MONOPTEROS in the Arabidopsis shoot. [PDF]
Kareem A, Ohno C, Heisler MG.
europepmc +1 more source
The old pea model in a new light: power of auxin over photoassimilates. [PDF]
Balla J +3 more
europepmc +1 more source
Based on 3D-QSAR modeling and molecular dynamics of novel peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 inhibitors design and screening. [PDF]
Xu D, Li J, Li Y, Dou J.
europepmc +1 more source
Pre-clinical evaluation of a potent and effective Pin1-degrading agent in pancreatic cancer. [PDF]
Alboreggia G +9 more
europepmc +1 more source

